These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25931215)

  • 1. [Association of serum level of apolipoprotein M with disease activity in systemic lupus erythematosus].
    DU W; Wang L; Li H; Liu Y; Shen T; Hu M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 40(4):367-72. PubMed ID: 25931215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low apolipoprotein M serum levels correlate with Systemic lupus erythematosus disease activity and apolipoprotein M gene polymorphisms with Lupus.
    Du W; Shen T; Li H; Liu Y; He L; Tan L; Hu M; Ren Y
    Lipids Health Dis; 2017 May; 16(1):88. PubMed ID: 28476116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low plasma concentrations of apolipoprotein M are associated with disease activity and endothelial dysfunction in systemic lupus erythematosus.
    Tydén H; Lood C; Jönsen A; Gullstrand B; Kahn R; Linge P; Kumaraswamy SB; Dahlbäck B; Bengtsson AA
    Arthritis Res Ther; 2019 May; 21(1):110. PubMed ID: 31046824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulated serum lipid profile and its correlation to disease activity in young female adults diagnosed with systemic lupus erythematosus: a cross-sectional study.
    Zhou B; Xia Y; She J
    Lipids Health Dis; 2020 Mar; 19(1):40. PubMed ID: 32171306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
    Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
    J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
    Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
    Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG; Giles I; Lambrianides A; Manson J; D'Cruz D; Schrieber L; March LM; Latchman DS; Isenberg DA; Rahman A
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-reactivity between anti-cardiolipin, anti-high-density lipoprotein and anti-apolipoprotein A-I IgG antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Kumar S; Isenberg DA
    Rheumatology (Oxford); 2003 Jul; 42(7):893-9. PubMed ID: 12730551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein A1 in association with anticardiolipin antibodies in patients with systemic lupus erythematosus.
    Lahita RG; Rivkin E; Cavanagh I; Romano P
    Arthritis Rheum; 1993 Nov; 36(11):1566-74. PubMed ID: 8240433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PGLYRP2 as a novel biomarker for the activity and lipid metabolism of systemic lupus erythematosus.
    Li H; Meng D; Jia J; Wei H
    Lipids Health Dis; 2021 Aug; 20(1):95. PubMed ID: 34461924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus.
    Vordenbäumen S; Fischer-Betz R; Timm D; Sander O; Chehab G; Richter J; Bleck E; Schneider M
    Lupus; 2010 Dec; 19(14):1648-53. PubMed ID: 20724351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
    Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
    Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
    Tripathy R; Panda AK; Das BK
    Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Correlation Between Serum Hcy Level and Clinical Indicators in Systemic Lupus Erythematosus Patients].
    Ding XJ; Chen Y; Duan X; Wang L; Liu Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 50(4):619-621. PubMed ID: 31642246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serum levels of soluble Fas (CD95/Apo-1) with disease activity in systemic lupus erythematosus patients in Khorasan, Iran.
    Sahebari M; Hatef MR; Rezaieyazdi Z; Abbasi M; Abbasi B; Mahmoudi M
    Arch Iran Med; 2010 Mar; 13(2):135-42. PubMed ID: 20187668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International multi-center evaluation of a novel chemiluminescence assay for the detection of anti-dsDNA antibodies.
    Bentow C; Lakos G; Martis P; Wahl E; Garcia M; Viñas O; Espinosa G; Cervera R; Sjöwall C; Carmona-Fernandes D; Santos MJ; Hanly JG; Mahler M
    Lupus; 2016 Jul; 25(8):864-72. PubMed ID: 27252263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus.
    Morel J; Roubille C; Planelles L; Rocha C; Fernandez L; Lukas C; Hahne M; Combe B
    Ann Rheum Dis; 2009 Jun; 68(6):997-1002. PubMed ID: 18676986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies against High Mobility Group Box protein-1 (HMGB1) versus other anti-nuclear antibody fine-specificities and disease activity in systemic lupus erythematosus.
    Wirestam L; Schierbeck H; Skogh T; Gunnarsson I; Ottosson L; Erlandsson-Harris H; Wetterö J; Sjöwall C
    Arthritis Res Ther; 2015 Nov; 17():338. PubMed ID: 26596890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus.
    Morgan PE; Sturgess AD; Davies MJ
    Arthritis Rheum; 2005 Jul; 52(7):2069-79. PubMed ID: 15986354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.